ClinicalTrials.Veeva

Menu

Glycemic Response Testing

PepsiCo logo

PepsiCo

Status

Completed

Conditions

Glycemic Response

Treatments

Other: Dietary Intervention

Study type

Interventional

Funder types

Industry

Identifiers

NCT02020798
PEP-1328

Details and patient eligibility

About

The purpose of this study is to assess whether food ingredient(s) affect glycemic responses.

Enrollment

38 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subject is 18-75 years of age
  • Subject has a body mass index (BMI) ≥ 20.0 and < 35 kg/m² at screening (visit 1).
  • Subject has normal fasting serum glucose (<7.0mmol/L capillary corresponding to whole blood glucose <6.3mmol/L).
  • Subject has no health conditions that would prevent him from fulfilling the study requirements as judged by the Investigator on the basis of medical history.
  • Subject understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study investigator.

Exclusion criteria

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

38 participants in 2 patient groups, including a placebo group

Nutrient formulations without active ingredient
Placebo Comparator group
Description:
4 nutrient formulations without active ingredient and variable level of available placebo ingredient
Nutrient formulation with active ingredien
Experimental group
Description:
4 nutrient formulations with increasing amount of active ingredient
Treatment:
Other: Dietary Intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems